 The clinical spotlight program is designed to facilitate the adoption of evidence-based practices in clinical settings by providing education, process improvement and support. The program has been successfully used to increase the use of newer classes of glycemic control medications among patients with type 2 diabetes. This article was authored by Craig Blackmore, Donna Smith, Kavita Chovla, and others.